Summary. Fifty-nine Type I (insulin-dependent) diabetic patients with (group I) and 59patients without nephropathy (group II) pair-matched according to sex (30 males and 29 females), age (33years, range 15-48) and diabetes duration (19 years, range 6-42) were followed for a period of 10years from about 5 years before to 5 years after onset of proteinuria. The cumulative incidence of coronary heart disease was estimated, and blood pressure and serum cholesterol were followed. Within six years after onset of proteinuria the cumulative incidence of coronary heart disease was increased eight-fold in group I (40%) compared with group II (5%), (p < 0.001). Blood pressure was higher in group I compared with group lI from before onset of proteinuria (135/86+ 17/9 mmHg vs 129/80_+ 15/8 mmHg, p < 0.001), and serum cholesterol elevated from onset of proteinuria in group I (6.3 _ 1.2 mmol/1) vs. group II (5.5 + 1.0 mmol/1), (p < 0.005). Patients in group I who developed coronary heart disease had similar age (36 years, range 21-51, vs 38 years, range 21-53), sex (50% males vs. 52% males), smoking frequency (50% vs 49%), diabetes duration (22years, range 9-39, vs 24years, range 10-42) and serum creatinine (110 ~xmol/1, range 69-284, vs 108 ~tmol, range 72-1024) compared with patients not developing coronary heart disease. However, the patients with coronary heart disease had higher blood pressure (135/87 mmHg_+ 16/9 vs 128/82_+ 15/7, p < 0.05) and serum cholesterol (7.3 mmol/1 + 1.2 vs 6.4 mmol/l_+ 0.9, p < 0.05) than patients without coronary heart disease. Thus, patients developing clinical nephropathy have a highly increased incidence of coronary heart disease compared with patients not developing nephropathy. Patients who developed coronary heart disease were characterized by higher blood pressure and serum cholesterol.
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Congestive heart failure and ischaemic heart disease are major complications of diabetes mellitus [1, 2] . Recent studies have shown that increased urinary protein excretion in Type ! (insulin-dependent) [3] as well as in Type 2 (non-insulin-dependent) [4, 5] diabetic patients is a predictor of cardiovascular death. Angiographic studies of diabetic patients with chronic renal failure have shown severe and widespread occlusive atherosclerosis of the coronary arteries [6] , and impaired left ventricular function has been found in young diabetic patients with retinopathy and nephropathy [7, 8] . The cause of this increased frequency of cardiovascular disease among patients with clinical nephropathy remains unknown. However, insulin-dependent diabetic patients with nephropathy have elevated blood pressure [9, 10] , higher smoking frequency [11] , increased transcapillary escape rate of albumin [12] , increased plasma fibrinogen and increased total cholesterol [13] when compared with patients without clinical nephropathy. The purpose of our study was to investigate the incidence of coronary heart disease (CHD) and its associations to blood pressure, serum cholesterol and smoking in a cohort of young insulin-dependent diabetic patients during early clinical nephropathy.
Subjects and methods
All patients with Type I diabetes mellitus (onset before age 31 years) and current age between 18 and 50 years, who during their follow-up 1975-81 at the Steno Memorial Hospital developed clinical nephropathy, were included in the study (group I, n = 59). Clinical nephropathy was defined as (1) urinary protein excretion exceeding 0.5 g/day at four consecutive visits to the outpatient clinic, and (2) no clinical or laboratory evidence of renal tract infection or kidney disease other than glomerulosclerosis. From our records of patients known not to have developed diabetic nephropathy, 4-10 subjects matched according to sex, age (+ 5 years) and diabetes duration (+ 5 years) were identified for each patient (total 278 subjects). Of these, 59 control subjects were selected randomly (group II). All patients were seen in Myocardial ischaemia (ECG-changes) Minnesota-code 1. 1.9-lead (I, II, III, V1-6) resting ECG (mean interval 3 years). The records were coded independently in duplicate by trained and tested technicians using the Minnesota-code [14] . 2. Clinical coronary heart disease. Autopsy verified myocardial infarction or non-fatal myocardial infarction according to the WHO criteria [15] . Angina pectoris defined in accordance with Rose [16] . Patients were defined to have coronary heart disease (CHD) when: resting ECG showed signs of probable myocardial infarction (Minnesotacode 1.1-2) or possible myocardial ischaemia (Minnesota-code 1.3, 4.1-4, 5.1-3 or 7.1), or when clinical coronary heart disease as defined above was present.
3. Blood pressure (mean interval 3 years) with a standard clinical sphygmomanometer (cuff 25 x 12 cm) with the subject in the supine position for at least 10 rain. Diastolic blood pressure was measured at disappearance of of the Korotkoff sounds (phase 5). From all blood pressure measurements mean systolic and diastolic blood pressure were calculated in the periods before, at and after onset of proteinuria for each patient. 4. Serum cholesterol(mean interval 2 years) was determined according to Abell [17] . From all values mean serum cholesterol was calculated in the periods before, at and after onset of proteinnria for each patient. 5. Serum ereatinine was measured by a reaction rate method eliminating pseudocreatinines [18] .
The eye backgroundwas examined by opthalmoscopy through the dilated pupil and classified as normal, simplex or proliferative retinopathy.
Proteinuria was tested at each outpatient visit (every third month) with Albustix (Boehringer, Mannheim, FRG). If the qualitative reaction was positive a quantitative examination was performed by Tsuchiya's method [19] .
Smokers were defined as those smoking more than one cigarette per day, all others being classified as non-smokers.
Statistical analysis
Results are given as mean + SD and median and range when values were normal or not normally distributed respectively. Paired and unpaired Student's t-tests were used for comparison within and between groups. The Maim-Whitney test was used for comparison between groups when values were not normally distributed. For evaluating frequencies the chi-squared test was used. Cumulative incidences of CHD were calculated using actuarial lifetable analysis. Levels of significance were found by Gehan's test. The risk of Type I error was set atp<O.05.
Results
The patients' clinical data at onset of proteinuria are shown in Table 1 . The perfect match of the two groups regarding sex, age and diabetes duration is demonstrated. The mean follow-up in group I was 5 years prior to and 5.1 years after onset of proteinuria. Group II was followed to the same age and diabetes duration.
All patients had initially normal ECG and no clinical symptoms of coronary heart disease. In group I two patients developed CHD before onset of proteinuria and 20 patients developed CHD after. The corresponding values in group II were 1 and 5 respectively (p < 0.001). The characteristics of CHD in the two groups are shown in Table 2 . The 59 pairs were followed for 2-9years after onset of proteinuria, but only 9pairs were followed for more than 6 years. Within the first 6 years after onset of proteinuria, the cumulative incidence of CHD calculated by actuarial lifetable analysis was eight times higher among patients with clinical nephropathy compared with patients without proteinuria (Fig. 1) . At the start of the study blood pressure was equal in group I and II (127/80+15/7mmHg vs 126/78 + 16/8 mmHg). However, as shown in Figure 2 , blood pressure rose in group I even in the period before onset of proteinuria (135/86 + 17/9 mmHg vs Years after onset of proteinuria 129/80 _+ 15/8 mmHg, p < 0.01). Hypertension (diastolic blood pressure >__ 95 mmHg) was found in 25 (43%) of the proteinuric patients at onset of proteinuria. In addition, 21 patients developed hypertension after onset of proteinuria and antihypertensive treatment was initiated. Only 6patients (10%) in group II developed hypertension after the same diabetes duration. Serum cholesterol was similar in group I and II at the start of the study (5.7 _+1.1 mmol/1 vs 5.5 _+ 1.0 mmol/1) and, as shown in Figure 3 , in the period before onset of proteinuria. From onset of proteinuria serum cholesterol was elevated in group I (6.3_+ 1.2 mmol/1) compared with group II (5.5 _+ 1.0 mmol/1, p < 0.05). The number of smokers were equal in group I (29(49%)) and group II (33(56%)).
In the group of patients developing clinical nephropathy there was no difference as to age, sex, diabetes duration, smoking frequency or serum creatinine between the patients who developed CHD and those who did not (Table 3) . However, the patients with CHD had higher blood pressure and serum cholesterol compared with the patients without CHD.
Discussion
This study represents a case control within a cohort study of patients with insulin-dependent diabetes mellitus, with group I developing persistent proteinuria in the period 1975 to 1981 and group II not developing proteinuria during the follow-up period. Testing for proteinuria at each outpatient visit, and the exclusion of patients admitted to the Steno Memorial Hospital with persistent proteinuria, ensure the exact time of onset of proteinuria. As to the reliability of electrocardiograms, blood pressure measurements and cholesterol determinations, the conditions at examination were identical for both groups, and data from both groups were obtained during the same period.
Morphological studies have previously shown the co-existence of micro-and macrovascular abnormalities in diabetic patients. In 36 of 50 diabetic patients, Zoneraich et al. [20] found abnormalities in small intramural arteries. Half of these patients demonstrating small vessel disease also showed larger coronary artery occlusions. Using angiography Weinrauch [6] described widespread occlusive atherosclerosis of the coronary arteries in 9 of 21 asymptomatic diabetic patients with end-stage renal disease. In other studies, however, heart failure has been attributed to small vessel disease of the coronary circulation with relatively normal coronary arteries [21, 22] . Our study demonstrated an excessively high incidence of major electrocardiographic abnormalities and clinical coronary heart disease within the first years after onset of proteinuria in young diabetic patients compared with diabetic patients without proteinuria. This observation is new, and is in accordance with the increased relative mortality in patients with diabetic nephropathy shown in previous studies [3] [4] [5] . It also fits with previous findings of a huge increase of cardiovascular mortality found in patients with proteinuria [4, 5, 23] . The low annual incidence of coronary heart disease in our diabetic patients without proteinuria is in accordance with the only slightly increased relative mortality seen in patients without proteinuria [3, 23] .
In this study the high incidence of coronary heart disease among proteinuric patients was not confined to males or smokers. On the contrary, patients with and without proteinuria were comparable as to smoking frequency and male/female ratio. Smoking did not influence the development of coronary heart disease in the proteinuric patients.
In agreement with others, our study demonstrated elevated blood pressure and serum cholesterol in diabetic patients with proteinuria compared with diabetic patients without proteinuria [9, 10, 13] . Elevated serum cholesterol has long been noted in patients with nondiabetic nephrosis [24] . Although the mechanism responsible remains unknown, much evidence supports increased hepatic lipoprotein production as the principal contribution to elevated levels of cholesterol [25, 26] . It is widely held that elevated blood pressure [27] and serum cholesterol [28] are major contributors to coronary heart disease. In the recent Lipid Research Clinics Coronary Primary Prevention Trial among middle-aged men, a reduction in total cholesterol of only 8% resulted in a 20% decrease in cardiovascular mortality. On the other hand, it seems unlikely that the observed changes in blood pressure and serum cholesterol fully explain the huge increase in coronary heart disease among patients with diabetic nephropathy. Further studies are needed to clarify the influence of haemostatic abnormalities and changes in vascular permeability, especially of lipoproteins, in these patients.
It is not known whether reduction of blood pressure and serum cholesterol in patients with diabetic nephropathy will decrease the incidence of CHD. However, the increasing evidence from preventive trials in non-diabetic populations makes controlled intervention studies focusing on the elevated blood pressure and lipid abnormalities in this high risk group of Type 1 diabetic patients highly attractive.
